{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:08:05Z","timestamp":1784070485383,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The anti-coagulation protocol of patients with hemorrhage risk primary disease who need extracorporeal membrane oxygenation (ECMO) supported is controversial. This study evaluated the feasibility of a new anti-coagulation strategy, that is heparin-free after 3000\u2009IU heparin loaded in veno-venous ECMO (VV ECMO) supported acute respiratory failure patients with hemorrhage risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective study was performed in a series of hemorrhage risk patients supported with VV ECMO at the First Affiliated Hospital of Zhengzhou University, between June 2012 to Sept 2020. A total of 70 patients received a low heparin bolus of 3000 units for cannulation but without subsequent, ongoing heparin administration. Patients were divided into survival (<jats:italic>n<\/jats:italic>\u2009=\u200925) and non-survival group (<jats:italic>n<\/jats:italic>\u2009=\u200945). Data of coagulation, hemolysis and membrane lung function were calculated and analyzed. The complications of patients were recorded. Finally, the binary Logistic regression was conducted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The longest heparin-free time was 216\u2009h, and the mean heparin-free time was 102\u2009h. Compared with survivors, the non-survivors were showed higher baseline SOFA score and lower platelet counts in 0.5\u2009h, 24\u2009h, 48\u2009h and 96\u2009h after ECMO applied. However, there was no significant differences between survivors and non-survivors in ACT, APTT, INR, D-dimer, fibrinogen, LDH, blood flow rate, \u0394p and P<jats:sub>post-ML<\/jats:sub>O<jats:sub>2<\/jats:sub> (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) of all different time point. Moreover, only the baseline SOFA score was significantly associated with mortality (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, OR(95%CI): 2.754 (1.486\u20135.103)) while the baseline levels of ACT, APTT, INR, platelet, D-dimer, fibrinogen and LDH have no association with mortality. The percentage of thrombosis complications was 54.3% (38\/70) including 3 oxygenator changed but there was no significant difference of complications in survival and non-survival groups (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The anticoagulation protocol that no heparin after a 3000 units heparin bolus in VV ECMO supported acute respiratory failure patients with hemorrhage risk is feasible.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12959-022-00396-w","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T09:03:12Z","timestamp":1656320592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Heparin-free after 3000\u2009IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy"],"prefix":"10.1186","volume":"20","author":[{"given":"Yang-Chao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Bai","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Fu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"396_CR1","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","volume":"378","author":"A Combes","year":"2018","unstructured":"Combes A, Hajage D, Capellier G, Demoule A, Lavou\u00e9 S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965\u201375.","journal-title":"N Engl J Med"},{"key":"396_CR2","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.21037\/jtd.2017.11.05","volume":"9","author":"S Kreyer","year":"2017","unstructured":"Kreyer S, Muders T, Theuerkauf N, Spitzh\u00fcttl J, Schellhaas T, Schewe J-C, et al. Hemorrhage under veno-venous extracorporeal membrane oxygenation in acute respiratory distress syndrome patients: a retrospective data analysis. J Thorac Dis. 2017;9:5017\u201329.","journal-title":"J Thorac Dis"},{"key":"396_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jcrc.2017.02.014","volume":"39","author":"E Sy","year":"2017","unstructured":"Sy E, Sklar MC, Lequier L, Fan E, Kanji HD. Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis. J Crit Care. 2017;39:87\u201396.","journal-title":"J Crit Care"},{"key":"396_CR4","unstructured":"Extracorporeal Life Support Organization. ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support Version 1.4. 2017. http:\/\/www.elso.org\/Resources\/Guidelines.aspx."},{"key":"396_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/vox.12514","volume":"112","author":"SA Esper","year":"2017","unstructured":"Esper SA, Welsby IJ, Subramaniam K, John Wallisch W, Levy JH, Waters JH, et al. Adult extracorporeal membrane oxygenation: An international survey of transfusion and anticoagulation techniques. Vox Sang. 2017;112:443\u201352.","journal-title":"Vox Sang"},{"key":"396_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.healun.2019.01.1313","volume":"38","author":"J Raman","year":"2019","unstructured":"Raman J, Alimohamed M, Dobrilovic N, Lateef O, Aziz S. A comparison of low and standard anti-coagulation regimens in extracorporeal membrane oxygenation. J Heart Lung Transpl. 2019;38:433\u20139.","journal-title":"J Heart Lung Transpl"},{"key":"396_CR7","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1053\/j.jvca.2018.07.045","volume":"33","author":"MA Mazzef","year":"2019","unstructured":"Mazzef MA, Tanaka K, Roberts A, Rector R, Menaker J, Kon Z, et al. Bleeding, thrombosis, and transfusion with two heparin anticoagulation protocols in venoarterial ECMO patients. J Cardiothorac Vasc Anesth. 2019;33:1216\u201320.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"396_CR8","unstructured":"The Extracorporeal Life Support Organization (ELSO). ELSO Anticoagulation Guideline. 2014. http:\/\/www.elso.org\/Resources\/Guidelines.aspx."},{"key":"396_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1186\/s13054-020-03388-2","volume":"24","author":"B Zakhary","year":"2020","unstructured":"Zakhary B, Vercaemst L, Mason P, Antonini MV, Lorusso R, Brodie D. How I approach membrane lung dysfunction in patients receiving ECMO. Crit Care. 2020;24:671.","journal-title":"Crit Care"},{"key":"396_CR10","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/cc12681","volume":"17","author":"C Aubron","year":"2013","unstructured":"Aubron C, Cheng AC, Pilcher D, Leong T, Magrin G, Cooper DJ, et al. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study. Crit Care. 2013;17:R73.","journal-title":"Crit Care"},{"key":"396_CR11","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1513\/AnnalsATS.201605-364SR","volume":"13","author":"MC Sklar","year":"2016","unstructured":"Sklar MC, Sy E, Lequier L, et al. Anticoagulation practices during venovenous extracorporeal membrane oxygenation for respiratory failure. A systematic review. Ann Am Thorac Soc. 2016;13:2242\u201350.","journal-title":"Ann Am Thorac Soc"},{"key":"396_CR12","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1097\/PCC.0b013e31827127e4","volume":"14","author":"MM Bembea","year":"2013","unstructured":"Bembea MM, Annich G, Rycus P, et al. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: An international survey. Pediatr Crit Care Med. 2013;14:e77-84.","journal-title":"Pediatr Crit Care Med"},{"key":"396_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/SHK.0000000000000459","volume":"44","author":"NJ Prat","year":"2015","unstructured":"Prat NJ, Meyer AD, Langer T, Montgomery RK, Parida BK, Batchinsky AI, et al. Low-Dose Heparin Anticoagulation During Extracorporeal Life Support for Acute Respiratory Distress Syndrome in Conscious Sheep. Shock. 2015;44:560\u20138.","journal-title":"Shock"},{"key":"396_CR14","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1182\/blood.V128.22.3822.3822","volume":"128","author":"Z McQuilten","year":"2016","unstructured":"McQuilten Z, Aubron C, Bailey M, Board J, Buhr H, Dennis M, et al. Low-Dose Heparin in critically Ill Patients undergoing Extracorporeal Membrane Oxygenation -the Help ECMO Pilot Randomised Controlled Trial. Blood. 2016;128:3822.","journal-title":"Blood"},{"key":"396_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1186\/s13054-020-03348-w","volume":"24","author":"B Seeliger","year":"2021","unstructured":"Seeliger B, D\u00f6bler M, Friedrich R, Stahl K, K\u00fchn C, Bauersachs J, et al. Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure. Crit Care. 2021;24:701.","journal-title":"Crit Care"},{"key":"396_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1053\/j.jvca.2010.06.013","volume":"25","author":"AK Singh","year":"2011","unstructured":"Singh AK, Stearns G, Maslow A, Feng WC, Schwartz C. Redo sternotomy for cardiac reoperations using peripheral heparin-bonded cardiopulmonary bypass circuits without systemic heparinization: technique and results. J Cardiothorac Vasc Anesth. 2011;25:347\u201352.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"396_CR17","doi-asserted-by":"publisher","first-page":"E629","DOI":"10.21037\/jtd.2017.06.11","volume":"9","author":"A Bharat","year":"2017","unstructured":"Bharat A, DeCamp MM. Veno-arterial extracorporeal membrane oxygenation without therapeutic anticoagulation for intra-operative cardiopulmonary support during lung transplantation. J Thorac Dis. 2017;9:E629\u201331.","journal-title":"J Thorac Dis"},{"key":"396_CR18","first-page":"69","volume":"16","author":"DG Herbert","year":"2014","unstructured":"Herbert DG, Buscher H, Nair P. Prolonged venovenous extracorporeal membrane oxygenation without anticoagulation: a case of Good-pasture syndrome-related pulmonary haemorrhage. Crit Care Resusc. 2014;16:69\u201372.","journal-title":"Crit Care Resusc"},{"key":"396_CR19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.chest.2019.10.021","volume":"157","author":"B Seeliger","year":"2020","unstructured":"Seeliger B, Stahl K, Schenk H, Schmidt JJ, Wiesner O, Welte T, et al. Extracorporeal membrane oxygenation for severe ARDS due to immune diffuse alveolar hemorrhage: a retrospective observational study. Chest. 2020;157:744\u20137.","journal-title":"Chest"},{"key":"396_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s11748-018-0990-2","volume":"67","author":"M Takagaki","year":"2019","unstructured":"Takagaki M, Yamaguchi H, Ikeda N, Takeda K, Kasai F, Yahagi K, et al. Postcardiotomy venovenous extracorporeal membrane oxygenation without heparinization. Gen Thorac Cardiovasc Surg. 2019;67:982\u20136.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"396_CR21","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1097\/TA.0b013e31824d68e3","volume":"72","author":"RM Muellenbach","year":"2012","unstructured":"Muellenbach RM, Kredel M, Kunze E, Kranke P, Kuestermann J, Brack A, et al. Prolonged heparin-free extracorporeal membrane oxygenation in multiple injured acute respiratory distress syndrome patients with traumatic brain injury. J Trauma Acute Care Surg. 2012;72:1444\u20137.","journal-title":"J Trauma Acute Care Surg"},{"key":"396_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.healun.2019.01.1313","volume":"38","author":"R Jaishankar","year":"2019","unstructured":"Jaishankar R, Mazahir A, Nikola D, Omar L, Salim A. A comparison of low and standard anti-coagulation regimens in extracorporeal membrane oxygenation. J Heart Lung Transpl. 2019;38:433\u20139.","journal-title":"J Heart Lung Transpl"},{"key":"396_CR23","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1097\/CCM.0000000000003780","volume":"47","author":"C Aubron","year":"2019","unstructured":"Aubron C, McQuilten Z, Bailey M, Board J, Buhr H, Cartwright B, et al. Low-Dose Versus Therapeutic Anticoagulation in Patients on Extracorporeal Membrane Oxygenation: A Pilot Randomized Trial. Crit Care Med. 2019;47:e563\u201371.","journal-title":"Crit Care Med"},{"key":"396_CR24","unstructured":"Extracorporeal Life Support Organization. ECLS registry report: international summary. https:\/\/www.elso.org\/Registry\/Statistics\/InternationalSummary.aspx."},{"key":"396_CR25","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/MAT.0000000000000133","volume":"60","author":"C Dornia","year":"2014","unstructured":"Dornia C, Philipp A, Bauer S, Lubnow M, Muller T, Lehle K, et al. Analysis of thrombotic deposits in extracorporeal membrane oxygenators by multidetector computed tomography. ASAIO J. 2014;60:652\u20136.","journal-title":"ASAIO J"},{"key":"396_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fmed.2018.00352","volume":"5","author":"AJ Doyle","year":"2018","unstructured":"Doyle AJ, Hunt BJ. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med Lausanne). 2018;5:352.","journal-title":"Front Med Lausanne)"},{"key":"396_CR27","doi-asserted-by":"publisher","first-page":"e112316","DOI":"10.1371\/journal.pone.0112316","volume":"9","author":"M Lubnow","year":"2014","unstructured":"Lubnow M, Philipp A, Foltan M, Bull Enger T, Lunz D, Bein T, et al. Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange-retrospective analysis of 265 cases. PLoS ONE. 2014;9:e112316.","journal-title":"PLoS ONE"},{"key":"396_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5301\/ijao.5000498","volume":"39","author":"SM Hastings","year":"2016","unstructured":"Hastings SM, Deshpande SR, Wagoner S, Maher K, Ku DN. Thrombosis in centrifugal pumps: location and composition in clinical and in vitro circuits. Int J Artif Organs. 2016;39:200\u20134.","journal-title":"Int J Artif Organs"},{"key":"396_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/MAT.0b013e318186a807","volume":"54","author":"K Lehle","year":"2008","unstructured":"Lehle K, Philipp A, Gleich O, Holzamer A, Muller T, Bein T, et al. Efciency in extracorporeal membrane oxygenation-cellular deposits on polymethylpentene membranes increase resistance to blood flow and reduce gas exchange capacity. ASAIO J. 2008;54:612\u20137.","journal-title":"ASAIO J"},{"key":"396_CR30","doi-asserted-by":"publisher","first-page":"S596","DOI":"10.21037\/jtd.2017.10.05","volume":"10","author":"F Epis","year":"2018","unstructured":"Epis F, Belliato M. Oxygenator performance and artificial-native lung interaction. J Thorac Dis. 2018;10:S596-605.","journal-title":"J Thorac Dis"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-022-00396-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-022-00396-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-022-00396-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T09:12:48Z","timestamp":1656321168000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-022-00396-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["396"],"URL":"https:\/\/doi.org\/10.1186\/s12959-022-00396-w","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study fully complied with the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China (no. 2020-KY-429). Informed consent was waived because of the retrospective nature of the analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}